MedTrace Logo

Treatment of Extracorporeal Membrane Oxygenation in Severe Poisoning

NCT05762029 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2023-03-09

No results posted yet for this study

Summary

This is a prospective, multicentre clinical study to determine the value of the Extracorporeal Membrane Oxygenation in the treatment of critically ill poisoning patients and whether there are significant differences in the prognosis of different types or doses of poison/drug poisoning. These conclusions may guide us on how to correctly perform Extracorporeal Membrane Oxygenation, including whether or when should this treatment enabled, the mode of Extracorporeal Membrane Oxygenation, whether to combine blood purification, treatment schedule and disembarkation time.

Conditions

  • Poison;Medicinal
  • Extracorporeal Membrane Oxygenation

Sponsors & Collaborators

  • Affiliated Hospital of Nantong University

    lead OTHER

Principal Investigators

  • Zhongwei Huang · Affiliated Hospital of Nantong University

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-26
Primary Completion
2025-11-26
Completion
2025-11-26

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05762029 on ClinicalTrials.gov